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Cells. Human breast cancer MCF-7 and MDA-231 cells were routinely grown as already described (2). To evaluate the effect of estrogen challenge, cells were first incubated with phenol red-free DMEM with 0.5% dextran-charcoal-stripped FCS for 6-8 h, and then with the same medium containing 5% dextran-charcoal stripped FCS for further 4 days, prior to be challenged with 10 nM E2 for different times according to the experimental needs. To obtain expression of ERα in MDA-231, cells were co-transfected with pSG5-HEGO plasmid expressing human estrogen receptor and the pMACS4-IRES.II vector, used to select transfected cells, according to MACSelect TM System instructions. Human primary fibroblasts were grown in DMEM with 10% FBS prior to be treated as described above for breast cancer cells, in order to evaluate the effects of E2 challenge. In experiments with ICI 182,780, the anti-estrogen (1 µM) was added concomitantly with 10 nM E2.
To inhibit LSD1 activity, 3 mM pargyline was added to cells for 14-16 h. To obtain LSD1 knock down with siRNAs, cells were transfected with 37.5 ng of AOF2-1 or AOF2-5 siRNAs targeting protein coding region (Qiagen Inc., USA) or the 3'-untranslated region (customer service, Quiagen, USA), in medium without serum to a final concentration of 5nM and incubation was continued for 72 h. Sch scrambled RNA (1 µl) was used as negative control. The same procedure was used to get OGG1 and topoisomerase IIβ knock down with the specific siRNAs sc-43983 and sc-36697 (Santa Cruz Biotechnology Inc., USA), respectively. To determine rescue of LSD1 activity in knock down experiments with siRNAs, LSD1 full-length cDNA was inserted into the CMV 3xflag expression vector (Sigma-Aldrich, USA). To obtain the mutant, catalytically inactive form, a cDNA encoding a protein lacking the C-terminal tail (BamH1-digested) was used.
ChIP and sequential ChIP (re-ChIP). ChIP assays were carried out as previously reported (4).
Chromatin was sonicated in order to obtain fragments of 300-400 bp. For each assay, chromatin from a total of 10 6 cells was used. In re-ChIP experiments, complexes were eluted from the primary 2 ChIP by incubation with 10 mM DTT at 37°C for 30 min and diluted 1:40 in buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH8.1) before being re-immunoprecipitated with the secondary antibodies. Re-ChIP of supernatants was performed essentially as for primary immunoprecipitations. All bands from ethidium bromide stained gels were analyzed by densitometry and quantified with two independent programs: Scion Image for Windows and Mac OS (Scion Corporation, USA), and Multi-analyst Biorad version 1.1 (Biorad Laboratories, USA).
The antibodies used were as follows: anti-ERα Ab 314 and Ab 1603 were prepared as already Nuclear run-on. Run-on assays were realized as previously reported (4). Briefly, cell nuclei were extracted by addition of NP-40 lysis buffer (10 mM Tris-HCl, pH 7.44; 10 mM NaCl; 3 mM MgCl2; and 0.5% NP-40) and stored in glycerol buffer (50 mM Tris-HCl, pH 8.3; 40% glycerol; 5 mM MgCl2; 0.1 mM EDTA). Transcription was carried-out in the presence of 5 µl of 10 mCi/ml [α-32 P]UTP. RNA samples (10 µg) were hybridized with plasmids (pcDNA3) containing cDNAs of bcl-2 or β-actin, immobilized on nylon filters.
Chromosome conformation capture (3C). 3C was realized as described previously (10 Zeiss axiomatic photomicroscope with a 63x objective. To obtain LSD1 knock down, 10 5 cells were transcfected in 24 multi-well plates with specific or control siRNAs following the protocol described above. After 72 h, cells were subjected to different treatments, according to experimental needs, and processed for fluorescence microscopy, as stated above. For single cell transfection assays, cells were co-transfected with siRNAs and 100 ng pDsRed1-N1 (Clonetech, USA). In both cases the efficiency of transfection was 65%+10.
Western blotting. To determine OGG1/2 levels, E2-deprived cells were treated with 10 nM E2 for 15 min in the absence or presence of 30 min pre-added MG132 (10 µM) or NAC (25 mM).
Treatment with 100 µM H 2 O 2 for 15 min was used as control. Thereafter, cells were washed in icecold PBS, and dissolved in lysis buffer (50 mM Tris-HCl, pH 7.4, 1% Nonidet NP-40, 300 mM NaCl, 1 mM MgCl 2, 2 mM EDTA, 50 mM NaF, 0.1 mM NaVO 3 , 1 mM glycerophosphate, 2.5 mM 
